37 results on '"Yamagami J"'
Search Results
2. 064 Early Clinical Score Changes Predict Additional Treatment Necessity In Pemphigus/Pemphigoid
3. Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti‐desmoglein IgG autoantibodies in remission: a retrospective cohort study
4. Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell–mediated inflammation in the skin
5. 037 Efficacy and safety of tirabrutinib, highly selective Bruton’s tyrosine kinase inhibitor, for oral treatment of pemphigus: a multicenter, open-label, uncontrolled, single-arm phase 2 study
6. 013 Fcγ receptor IIb-dependent blockade of immunoglobulin class-switch is crucial to prevent pemphigus onset in desmoglein 3-sepecific B cell receptor knock-in mouse
7. How certain molecules of the immune system affect bullous pemphigoid
8. 免疫系统的某些分子如何影响大疱性类天疱疮
9. A milestone in reaching the goal of complete remission off‐therapy in pemphigus
10. An adult case of X‐linked chronic granulomatous disease with skin ulcer on the nose and internal canthus
11. Results of the guideline‐based treatment for pemphigus: a single‐centre experience with 84 cases
12. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results
13. Inter‐rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients
14. Prediction of relapse in the treatment of pemphigus
15. 421 Pemphigus vulgaris IgG autoantibodies directly inhibit heterophilic desmoglein 3-desmocollin 3 adhesion by steric hindrance
16. Reorganization of serum analysis tools for the diagnosis of bullous pemphigoid
17. A two‐step immunoblot assay for serological diagnosis of anti‐laminin γ‐1 pemphigoid
18. Optic Disc Findings and Disc Hemorrhages in Low-Tension Glaucoma and Their Therapeutical Suggestion
19. Autoantibodies undetectable by chemiluminescent enzyme immunoassay require extended antigen–antibody reaction time for detection
20. Azathioprine-induced alopecia and leukopenia associated with NUDT15 polymorphisms
21. The International Bullous Diseases Group consensus on diagnostic criteria for epidermolysis bullosa acquisita: a useful tool for dermatologists
22. 059 Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts
23. 017 FcγRIIb deficiency accelerates immunoglobulin class switch and pemphigus phenotype development in pathogenic anti-desmoglein 3 antibody knock-in mice
24. Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
25. 053 Autoantibodies in vancomycin-induced linear IgA bullous dermatosis target type VII collagen in the presence of vancomycin
26. 010 FcgRIIb is important for clonal ignorance and prevents pemphigus phenotype in pathogenic anti-desmoglein 3 antibody knock-in mice
27. Evaluation of pharyngo‐oesophageal involvement in pemphigus vulgaris and its correlation with disease activity
28. 264 Patients with pemphigus foliaceus may retain antibody reactivity against calcium dependent epitopes of desmoglein 1 in remission
29. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages
30. Detection of Autoantibodies to Precursor Proteins of Desmogleins in Sera of a Patient with Bowen Carcinoma
31. Alopecia as a rare but distinct manifestation of pemphigus vulgaris
32. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission
33. Treadmill gait analysis 1: Extraction of gait pattern components from Lissajous figure by FFT smoother
34. The first case of cutaneous mucormycosis caused by Rhizopus azygosporus
35. EFFECTS OF I.P.P.B. THERAPY ON SILICOTIC PATIENTS
36. Cases of Subacute Silicosis found in a Clay Refinery
37. Changes of Cardiopulmonary Function under Seasonal Influence among the Hospitalized Pneumoconiotic Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.